跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Menarini International Operations Luxembourg S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 5, 2025
Approval ID
ed33f6daf8ae2e02
Company
Menarini International Operations Luxembourg S.A.
Type
Standard
Approval Details
Approval Id
ed33f6daf8ae2e02
Drug Cima Aemps Name
RANEXA 375 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
08462001IP3
Holder Company Name
Menarini International Operations Luxembourg S.A.
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Authorization Date
2025-02-05
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
375 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Menarini International Operations Luxembourg S.A.
Company Detail Path
/organization/menarini-international-operations-luxembourg-s-a
Company Information
Pharmaceutical Company Name
MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
Country Name
Luxembourg
City Name
luxembourg,country_lu
Address
Avenue de la Gare 1
Active Ingredients
RANOLAZINA
375 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 5, 2025
Approval ID
ed33f6daf8ae2e02
Type
Standard
Back to CIMA-AEMPS Approvals